|
|
 |
|
Viewing report
|
|
|
|
Abbott Laboratories: PharmaVitae Profile
Datamonitor, May 2011, Pages: 95
This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
- Gain insight into Abbott's strategic outlook across the next 6 years
- Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.
Highlights
Strategic insight into the prospects for Abbott over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
- Benchmark Abbott's performance against key rivals in the prescription pharmaceutical sector
- Discover how Abbott has utilized M&A to become one of the world's largest multi-disciplinary healthcare companies.
|
|
|
|
